Center-Authored Papers

Filters: Author is Martin, P J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Whole-Body Irradiation
Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Hui TE, Martin PJ, Mitchell D, Press OW, Storb R et al..  1999.  Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.. Blood. 94(4):1237-47. Abstract
Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Bush SA, Hui TE, Martin PJ, Mitchell D, Press OW.  1995.  Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.. Blood. 85(4):1122-31. Abstract
Tumor Cells, Cultured
Press OW, Farr AG, Borroz KI, Anderson SK, Martin PJ.  1989.  Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.. Cancer research. 49(17):4906-12. Abstract
Press OW, Hansen JA, Farr A, Martin PJ.  1988.  Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes.. Cancer research. 48(8):2249-57. Abstract
Tritium
Press OW, Vitetta ES, Martin PJ.  1986.  A simplified microassay for inhibition of protein synthesis in reticulocyte lysates by immunotoxins.. Immunology letters. 14(1):37-41. Abstract
Transplantation, Homologous
Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Hui TE, Martin PJ, Mitchell D, Press OW, Storb R et al..  1999.  Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.. Blood. 94(4):1237-47. Abstract
Transplantation, Autologous
Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durack LD et al..  2000.  A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.. Blood. 96(9):2934-42. Abstract
Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Hui TE, Martin PJ, Mitchell D, Press OW, Storb R et al..  1999.  Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.. Blood. 94(4):1237-47. Abstract
Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B.  1993.  Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.. The New England journal of medicine. 329(17):1219-24. Abstract
Transferrin
Press OW, Hansen JA, Farr A, Martin PJ.  1988.  Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes.. Cancer research. 48(8):2249-57. Abstract
Tissue Preservation
Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp WB, Krohn KA.  1989.  Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 7(8):1027-38. Abstract
TISSUE DISTRIBUTION
Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Bush SA, Hui TE, Martin PJ, Mitchell D, Press OW.  1995.  Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.. Blood. 85(4):1122-31. Abstract
Matthews DC, Appelbaum FR, Eary JF, Hui TE, Fisher DR, Martin PJ, Durack LD, Nelp WB, Press OW, Badger CC.  1991.  Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.. Blood. 78(7):1864-74. Abstract
Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durack LD et al..  2000.  A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.. Blood. 96(9):2934-42. Abstract
Bernstein ID, Eary JF, Badger CC, Press OW, Appelbaum FR, Martin PJ, Krohn KA, Nelp WB, Porter B, Fisher D.  1990.  High dose radiolabeled antibody therapy of lymphoma.. Cancer research. 50(3 Suppl):1017s-1021s. Abstract
Time Factors
Appelbaum FR, Matthews DC, Eary JF, Badger CC, Kellogg M, Press OW, Martin PJ, Fisher DR, Nelp WB, Thomas ED.  1992.  The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.. Transplantation. 54(5):829-33. Abstract
Tetraspanins
Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B.  1993.  Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.. The New England journal of medicine. 329(17):1219-24. Abstract
T-Lymphocytes
Mielcarek M, Martin PJ, Torok-Storb B.  1997.  Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.. Blood. 89(5):1629-34. Abstract
Press OW, Hansen JA, Farr A, Martin PJ.  1988.  Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes.. Cancer research. 48(8):2249-57. Abstract
Press OW, Martin PJ, Thorpe PE, Vitetta ES.  1988.  Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.. Journal of immunology (Baltimore, Md. : 1950). 141(12):4410-7. Abstract
Press OW, Vitetta ES, Farr AG, Hansen JA, Martin PJ.  1986.  Evaluation of ricin A-chain immunotoxins directed against human T cells.. Cellular immunology. 102(1):10-20. Abstract
Survival Rate
Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durack LD et al..  2000.  A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.. Blood. 96(9):2934-42. Abstract
Press OW, Eary JF, Appelbaum FR, Martin PJ, Nelp WB, Glenn S, Fisher DR, Porter B, Matthews DC, Gooley T.  1995.  Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.. Lancet. 346(8971):336-40. Abstract
Splenomegaly
Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Nelp WB, Krohn KA, Fisher D, Porter B, Thomas ED.  1990.  High-dose radioimmunotherapy of B cell lymphomas.. Frontiers of radiation therapy and oncology. 24:204-13;discussion225-7.
Spleen
Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Bush SA, Hui TE, Martin PJ, Mitchell D, Press OW.  1995.  Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.. Blood. 85(4):1122-31. Abstract